Cassava Sciences expands board to 9 with three new directors

FILANA THERAPEUTICS, INC.

Appointed Dr. Claude Nicaise, Pierre Gravier, and Robert Anderson, Jr. effective Dec 6, 2023.
Board expanded from 6 to 9 members; Anderson (Class I), Nicaise and Gravier (Class II).
Nicaise led regulatory/clinical roles resulting in 14 drug approvals; Gravier is CFO of PTC Therapeutics.
Anderson is former FBI Executive Assistant Director and cybersecurity expert.
No committees assigned; none have material interests in reportable transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.